Edition:
India

Keryx Biopharmaceuticals Inc (KERX.OQ)

KERX.OQ on NASDAQ Stock Exchange Capital Market

4.73USD
13 Dec 2017
Change (% chg)

$0.26 (+5.82%)
Prev Close
$4.47
Open
$4.47
Day's High
$4.78
Day's Low
$4.47
Volume
377,615
Avg. Vol
379,149
52-wk High
$8.37
52-wk Low
$4.33

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Jun '17 15.14 -0.768
Mar '17 11.82 -0.215
FY 2016 Dec '16 9.53 -0.319
Sep '16 6.34 -0.394
Jun '16 9.29 -0.422
Mar '16 6.82 -0.388
FY 2015 Dec '15 5.78 -0.359
Sep '15 4.21 -0.292
Jun '15 2.51 -0.257
Mar '15 1.17 -0.276
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 6 17.53 18.55 16.90 24.65
Quarter Ending Mar-18 3 24.11 28.31 19.69 27.98
Year Ending Dec-17 7 59.96 62.74 58.86 57.98
Year Ending Dec-18 8 119.29 177.60 94.50 130.21
Earnings (per share)
Quarter Ending Dec-17 7 -0.18 -0.12 -0.22 -0.06
Quarter Ending Mar-18 5 -0.13 -0.09 -0.18 0.03
Year Ending Dec-17 7 -1.35 -1.30 -1.40 -0.62
Year Ending Dec-18 7 -0.41 -0.30 -0.55 -0.12
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

Dividends

Growth Rates

Financial Strength

Profitability Ratios

Efficiency

Management Effectiveness

  1 Year 3 Year 5 Year
Sales % 133.79 65.94 44.94
EPS (TTM) % -28.41 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Keryx Biopharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 68.92%
# of Holders: 188
Total Shares Held: 81,842,857
3 Mo. Net Change: 1,435,601
# New Positions: 18
# Closed Positions: 10
# Increased Positions: 80
# Reduced Positions: 48
# Net Buyers: 32
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.